A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 278 shares of MEDP stock, worth $86,355. This represents 0.0% of its overall portfolio holdings.

Number of Shares
278
Previous 260 6.92%
Holding current value
$86,355
Previous $107,000 14.02%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$320.58 - $457.29 $5,770 - $8,231
18 Added 6.92%
278 $92,000
Q1 2024

May 15, 2024

BUY
$284.87 - $413.31 $74,066 - $107,460
260 New
260 $105 Million
Q4 2023

Aug 14, 2024

BUY
$227.52 - $312.68 $13,651 - $18,760
60 Added 37.5%
220 $67.4 Million
Q1 2022

Aug 14, 2024

SELL
$138.87 - $214.31 $13,887 - $21,431
-100 Reduced 38.46%
160 $26.2 Million
Q2 2021

Aug 30, 2024

SELL
$158.62 - $194.3 $15,862 - $19,430
-100 Reduced 38.46%
160 $28.3 Million
Q2 2020

Aug 30, 2024

SELL
$68.08 - $95.68 $534,904 - $751,757
-7,857 Reduced 98.0%
160 $14.9 Million
Q4 2019

Aug 30, 2024

SELL
$70.08 - $84.64 $2 Million - $2.41 Million
-28,474 Reduced 78.03%
8,017 $673 Million
Q3 2019

Aug 30, 2024

SELL
$62.38 - $85.89 $89,577 - $123,338
-1,436 Reduced 3.79%
36,491 $3.07 Billion
Q4 2018

Aug 30, 2024

BUY
$46.97 - $63.98 $1.77 Million - $2.41 Million
37,667 Added 14487.31%
37,927 $2.01 Billion
Q2 2018

Aug 30, 2024

BUY
$34.03 - $45.46 $295,346 - $394,547
8,679 Added 29.67%
37,927 $1.63 Billion
Q1 2018

Aug 30, 2024

BUY
$32.03 - $39.05 $842,517 - $1.03 Million
26,304 Added 893.48%
29,248 $1.02 Billion
Q1 2017

Aug 30, 2024

BUY
N/A
2,684
2,944 $87.9 Million

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $9.66B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.